AI for life science R&D
Omabit is a San Francisco company building AI to support scientific decision-making in drug development. It analyzes a life science company's own clinical, genomic and other R&D data, checks each finding against published research and writes it up, initially for clinical development, biomarker and translational teams. It announced $2M in seed financing led by Bright Ventures in October 2026.
For people
For agents
Nothing listed yet.